MIND THE GAP! How to Pave the Way to Access to Authorised ATMPs for Patients?

An event by the TRANSFORM MEP Interest Group

15:00 - 17:00 CET

Advanced Therapies Medicinal Products (ATMPs) are highly personalised treatments with the potential to transform the lives of patients.

This meeting has brought together policy-makers (MEPs, representatives of EU institutions, national representatives), regulators (EMA), patient representatives, medical experts, scientists, researchers, industry representatives and academics to discuss recommended changes in policy and practice, and to offer solutions to unlock patients’ access to ATMPs in Europe.

Confirmed Speakers

@TRANSFORM_CGT on Twitter Follow us →

TRANSFORM member MEP @nicogoncas speakes at the @EUBloodAlliance event on the new SoHO Regulation. R&D is advancing with SoHO-based therapies that have the potential to change lives of #patients. #MEPsforATMPs https://t.co/q1l7n8EwWr
25 January at 11:51am
SAVE THE DATES! TRANSFORM is back in 2️⃣0️⃣2️⃣3️⃣ and ready to shape the future of cell and gene therapies! 🗓️1 June (15:00 - 17:00) Policy webinar on the Pharmaceutical Package, online 🗓️24 October (afternoon) Conference in the European Parliament, In-person, Brussels #MEPsforATMPs
09 January at 1:17pm
Interesting event @alliancerm today! With the EU Pharma legislation review, the new HTA Regulation and the EHDS, the EU has an opportunity to encourage innovation & ensure that ATMPs are a central part of the EU’s healthcare landscape @Kympouropoulos @susanasolisp #MEPsforATMPs https://t.co/ODkSdMePW9
29 November at 9:07pm